These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7705451)

  • 1. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
    Laporte AM; Lima L; Gozlan H; Hamon M
    Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
    Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
    Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
    Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
    J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.
    Khawaja X
    Brain Res; 1995 Mar; 673(2):217-25. PubMed ID: 7606435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.
    Stenfors C; Werner T; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):500-7. PubMed ID: 9650801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
    Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
    Khawaja X; Evans N; Reilly Y; Ennis C; Minchin MC
    J Neurochem; 1995 Jun; 64(6):2716-26. PubMed ID: 7760052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
    Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
    Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A; Forster EA; Bill DJ; Brown G; Cliffe IA; Hartley JE; Jones DE; McLenachan A; Stanhope KJ; Critchley DJ; Childs KJ; Middlefell VC; Lanfumey L; Corradetti R; Laporte AM; Gozlan H; Hamon M; Dourish CT
    Behav Brain Res; 1996; 73(1-2):337-53. PubMed ID: 8788530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
    Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
    Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Alnespirone: a novel specific radioligand of 5-HT1A receptors in the rat brain.
    Fabre V; Boni C; Mocaër E; Lesourd M; Hamon M; Laporte AM
    Eur J Pharmacol; 1997 Oct; 337(2-3):297-308. PubMed ID: 9430429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.